Institutions / Novo Holdings A/S / Activity
Activity — Novo Holdings A/S
14 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | ZBIO Zenas BioPharma, Inc. Common Stock | $-52.65M | -1.4M -100.00% | 0 | high |
| Q1 2026 as of | Exit | Insmed Inc Common stock | $-34.81M | -200K -100.00% | 0 | medium |
| Q1 2026 as of | New | Xenon Pharmaceuticals Inc. Common stock | $28.23M | +485K | 485,438 2.29% of portfolio | medium |
| Q1 2026 as of | Trim | N07059210 Common stock | $-25.10M | -19K -16.67% | 94,946 10.16% of portfolio | medium |
| Q1 2026 as of | Add | Salesforce Inc Common stock | $11.76M | +63K +19.08% | 393,187 5.95% of portfolio | medium |
| Q1 2026 as of | Trim | Apogee Therapeutics, Inc. Common stock | $-10.10M | -120K -21.05% | 450,000 3.07% of portfolio | medium |
| Q1 2026 as of | Trim | ELVN Enliven Therapeutics, Inc. Common Stock | $-7.84M | -200K -13.51% | 1,280,000 4.07% of portfolio | medium |
| Q1 2026 as of | Trim | 92025Y103 Common stock | $-7.80M | -1.2M -54.12% | 1,057,421 0.54% of portfolio | medium |
| Q1 2026 as of | Trim | Viridian Therapeutics, Inc. Common stock | $-7.43M | -380K -15.97% | 2,000,000 3.17% of portfolio | medium |
| Q1 2026 as of | Add | Mirum Pharmaceuticals, Inc. Common stock | $5.63M | +61K +4.82% | 1,325,000 9.92% of portfolio | medium |
| Q1 2026 as of | Trim | Vaxcyte, Inc. Common stock | $-3.26M | -56K -6.13% | 860,000 4.05% of portfolio | low |
| Q1 2026 as of | Trim | Crinetics Pharmaceuticals, Inc. Common stock | $-2.72M | -75K -4.62% | 1,550,000 4.56% of portfolio | low |
| Q1 2026 as of | Add | BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock | $2.01M | +225K +11.45% | 2,185,923 1.59% of portfolio | low |
| Q1 2026 as of | Exit | IO Biotech, Inc. Common stock | $-1.53M | -2.5M -100.00% | 0 | low |